MRI Perfusion Equals FFR for Coronary Disease Evaluation
|
By MedImaging International staff writers Posted on 03 Jul 2019 |
A new study shows that non-invasive magnetic resonance imaging (MRI) measurement of cardiac blood flow is on par with cardiac catheterization.
Researchers at Goethe University Hospital (KGU; Frankfurt am Main, Germany), National University of Singapore (NUS, Singapore), the University of Leeds (United Kingdom), and other institutions conducted a multicenter, clinical-effectiveness trial to examine if a cardiovascular MRI–based strategy is non-inferior to an fractional flow reserve (FFR) cardiac catheterization angiography based strategy, with respect to major adverse cardiac events. The study included 918 patients with typical angina to a cardiovascular MRI–based strategy or an FFR-based strategy.
Revascularization was recommended for patients in the cardiovascular-MRI group with ischemia in at least 6% of the myocardium, or in the FFR group with an FFR of 0.8 or less. The composite primary outcome was death, nonfatal myocardial infarction (MI), or target-vessel revascularization within one year. The results revealed that in the MRI group, only 36% required a diagnostic cardiac catheterization and vascular dilation, compared to the FFR group (45 %). Importantly, the two groups did not differ in terms of continuing symptoms, the development of new symptoms, complications, or death. The study was published on June 20, 2019, in the New England Journal of Medicine (NEJM).
“Patients with stable chest pains who previously would have received cardiac catheterization can alternatively be examined with MRI,” concluded lead author Professor Eike Nagel, MD, of KGU. “The results for the patients are just as good, but an examination by MRI has many advantages: the procedure takes about 40 minutes, patients merely receive a small cannula in their arm, and are not subject to radiation.”
FFR is a physiological index used to determine the hemodynamic severity of atherosclerotic narrowing of the coronary arteries. It specifically identifies which coronary narrowing is responsible for the ischemic obstruction of the flow of blood to a patient’s heart muscle, and helps guide interventional cardiologists in determining which lesions warrant stenting, resulting in improved patient outcomes and reduced health care costs.
Related Links:
Goethe University Hospital
National University of Singapore
University of Leeds
Researchers at Goethe University Hospital (KGU; Frankfurt am Main, Germany), National University of Singapore (NUS, Singapore), the University of Leeds (United Kingdom), and other institutions conducted a multicenter, clinical-effectiveness trial to examine if a cardiovascular MRI–based strategy is non-inferior to an fractional flow reserve (FFR) cardiac catheterization angiography based strategy, with respect to major adverse cardiac events. The study included 918 patients with typical angina to a cardiovascular MRI–based strategy or an FFR-based strategy.
Revascularization was recommended for patients in the cardiovascular-MRI group with ischemia in at least 6% of the myocardium, or in the FFR group with an FFR of 0.8 or less. The composite primary outcome was death, nonfatal myocardial infarction (MI), or target-vessel revascularization within one year. The results revealed that in the MRI group, only 36% required a diagnostic cardiac catheterization and vascular dilation, compared to the FFR group (45 %). Importantly, the two groups did not differ in terms of continuing symptoms, the development of new symptoms, complications, or death. The study was published on June 20, 2019, in the New England Journal of Medicine (NEJM).
“Patients with stable chest pains who previously would have received cardiac catheterization can alternatively be examined with MRI,” concluded lead author Professor Eike Nagel, MD, of KGU. “The results for the patients are just as good, but an examination by MRI has many advantages: the procedure takes about 40 minutes, patients merely receive a small cannula in their arm, and are not subject to radiation.”
FFR is a physiological index used to determine the hemodynamic severity of atherosclerotic narrowing of the coronary arteries. It specifically identifies which coronary narrowing is responsible for the ischemic obstruction of the flow of blood to a patient’s heart muscle, and helps guide interventional cardiologists in determining which lesions warrant stenting, resulting in improved patient outcomes and reduced health care costs.
Related Links:
Goethe University Hospital
National University of Singapore
University of Leeds
Latest MRI News
- MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
- Novel Imaging Approach to Improve Treatment for Spinal Cord Injuries
- AI-Assisted Model Enhances MRI Heart Scans
- AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
- New MRI Technique Reveals Hidden Heart Issues
- Shorter MRI Exam Effectively Detects Cancer in Dense Breasts
- MRI to Replace Painful Spinal Tap for Faster MS Diagnosis
- MRI Scans Can Identify Cardiovascular Disease Ten Years in Advance
- Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable
- Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
- New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
- AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
- AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
- Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
- AI-Powered MRI Technology Improves Parkinson’s Diagnoses
- Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Channels
Radiography
view channel
Routine Mammograms Could Predict Future Cardiovascular Disease in Women
Mammograms are widely used to screen for breast cancer, but they may also contain overlooked clues about cardiovascular health. Calcium deposits in the arteries of the breast signal stiffening blood vessels,... Read more
AI Detects Early Signs of Aging from Chest X-Rays
Chronological age does not always reflect how fast the body is truly aging, and current biological age tests often rely on DNA-based markers that may miss early organ-level decline. Detecting subtle, age-related... Read moreUltrasound
view channel
Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
Chronic conditions such as hypertension and heart failure require close monitoring, yet today’s ultrasound imaging is largely confined to hospitals and short, episodic scans. This reactive model limits... Read more
Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
Producing clear 3D images of deep blood vessels has long been difficult without relying on contrast agents, CT scans, or MRI. Standard ultrasound typically provides only 2D cross-sections, limiting clinicians’... Read moreNuclear Medicine
view channel
PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
Acute myocardial infarction can trigger lasting heart damage, yet clinicians still lack reliable tools to identify which patients will regain function and which may develop heart failure.... Read more
Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
Aggressive cancers such as osteosarcoma and glioblastoma often resist standard therapies, thrive in hostile tumor environments, and recur despite surgery, radiation, or chemotherapy. These tumors also... Read more
New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read moreGeneral/Advanced Imaging
view channel
AI-Based Tool Predicts Future Cardiovascular Events in Angina Patients
Stable coronary artery disease is a common cause of chest pain, yet accurately identifying patients at the highest risk of future heart attacks or death remains difficult. Standard coronary CT scans show... Read more
AI-Based Tool Accelerates Detection of Kidney Cancer
Diagnosing kidney cancer depends on computed tomography scans, often using contrast agents to reveal abnormalities in kidney structure. Tumors are not always searched for deliberately, as many scans are... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read morePatient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more







